InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Sullivan Eddie Joe, 首席执行官. Director active across 1 company, notably SAB Biotherapeutics, Inc.. Aggregated, 3 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €12k. History available since 7 September 2022. The latest transaction was filed on 7 December 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Eddie Joe Sullivan is the Chief Executive Officer at SAB Biotherapeutics, Inc. He leads the operations of the company, implementing strategies to drive growth and innovation. His experience in the biopharmaceutical sector allows him to navigate effectively in complex environments.